[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DK0856312T3 - Anvendelse af trospiumchlorid til fremstilling af et lægemiddel til behandling af blæresygdomme - Google Patents

Anvendelse af trospiumchlorid til fremstilling af et lægemiddel til behandling af blæresygdomme

Info

Publication number
DK0856312T3
DK0856312T3 DK96118939T DK96118939T DK0856312T3 DK 0856312 T3 DK0856312 T3 DK 0856312T3 DK 96118939 T DK96118939 T DK 96118939T DK 96118939 T DK96118939 T DK 96118939T DK 0856312 T3 DK0856312 T3 DK 0856312T3
Authority
DK
Denmark
Prior art keywords
treatment
medicament
trospium chloride
manufacture
bladder
Prior art date
Application number
DK96118939T
Other languages
Danish (da)
English (en)
Inventor
Ulrich Dr Rer Nat Schwantes
Albert Schaupp
Manfred Dr Med Habil Stoehrer
Original Assignee
Pfleger R Chem Fab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8223435&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0856312(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfleger R Chem Fab filed Critical Pfleger R Chem Fab
Application granted granted Critical
Publication of DK0856312T3 publication Critical patent/DK0856312T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK96118939T 1996-11-27 1996-11-27 Anvendelse af trospiumchlorid til fremstilling af et lægemiddel til behandling af blæresygdomme DK0856312T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP96118939A EP0856312B1 (de) 1996-11-27 1996-11-27 Verwendung von Trospiumchlorid zur Herstellung eines Arzneimittels zur Behandlung von Blasenkrankheiten

Publications (1)

Publication Number Publication Date
DK0856312T3 true DK0856312T3 (da) 1999-06-23

Family

ID=8223435

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96118939T DK0856312T3 (da) 1996-11-27 1996-11-27 Anvendelse af trospiumchlorid til fremstilling af et lægemiddel til behandling af blæresygdomme

Country Status (8)

Country Link
US (1) US5998430A (es)
EP (1) EP0856312B1 (es)
JP (1) JPH10158169A (es)
AT (1) ATE172117T1 (es)
CA (1) CA2221900C (es)
DE (1) DE59600683D1 (es)
DK (1) DK0856312T3 (es)
ES (1) ES2125696T3 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100717660B1 (ko) 1999-07-01 2007-05-15 파마시아 앤드 업존 캄파니 엘엘씨 고선택성 노르에피네프린 재흡수 억제제 및 그의 이용 방법
US6974820B2 (en) * 2002-11-06 2005-12-13 Bridge Pharma, Inc. Methods for treating urinary incontinence and other disorders using trospium
US7056916B2 (en) * 2002-11-15 2006-06-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments for the treatment of chronic obstructive pulmonary disease
US20050009862A1 (en) * 2003-04-25 2005-01-13 Sabounjian Luann Method for promoting uninterrupted sleep by administration of trospium chloride
DK2210605T3 (en) * 2003-11-04 2017-05-22 Tcd Royalty Sub Llc Daily single dose doses of trospium.
WO2005046663A1 (en) 2003-11-04 2005-05-26 Shire Laboratories, Inc. Compositions of quaternary ammonium containing bioavailability enhancers
US7220742B2 (en) 2004-05-14 2007-05-22 Boehringer Ingelheim International Gmbh Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
US20050255050A1 (en) * 2004-05-14 2005-11-17 Boehringer Ingelheim International Gmbh Powder formulations for inhalation, comprising enantiomerically pure beta agonists
ATE427108T1 (de) * 2004-08-11 2009-04-15 Boehringer Ingelheim Pharma Anticholinergika enthaltende arzneimittel zur behandlung von krankheiten der ableitenden harnwege
US20060287347A1 (en) * 2005-06-21 2006-12-21 Aberg A K G Methods for treating smooth muscle disorders using trospium
US7390816B2 (en) * 2005-06-21 2008-06-24 Bridge Pharma, Inc. Methods for treating urinary incontinence in patients suffering from memory disorders
US20070004766A1 (en) * 2005-07-01 2007-01-04 Aberg A K G Methods for relaxation of smooth muscle contractions using Trospium
BRPI0614410A2 (pt) * 2005-08-15 2011-03-29 Boehringer Ingelheim Int processo para preparação de betamiméticos
WO2008019070A2 (en) * 2006-08-04 2008-02-14 Ebrahim Versi Pharmaceutical compositions of trospium for treating smooth muscle hyperactivity disorders
WO2014047221A1 (en) 2012-09-18 2014-03-27 Taris Biomedical, Inc. Drug delivery systems and methods for treatment of bladder voiding dysfunction|and other lower urinary tract disorders by using trospium
KR20210039403A (ko) * 2018-08-01 2021-04-09 타리스 바이오메디컬 엘엘씨 트로스피움을 사용한 과민성 방광의 치료 방법
CA3169487A1 (en) 2020-03-30 2021-10-07 Richard PHILIPSON Compositions and methods for treating cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1194422B (de) 1963-03-05 1965-06-10 Robert Pfleger Chem Fab Dr Verfahren zur Herstellung von Azoniaspironortropanderivaten
DE3546165A1 (de) * 1985-12-27 1987-10-15 Madaus & Co Dr Verwendung von azoniaspironortropanolestern als asthmatherapeutikum und als broncholytikum

Also Published As

Publication number Publication date
EP0856312B1 (de) 1998-10-14
CA2221900A1 (en) 1998-05-27
EP0856312A1 (de) 1998-08-05
US5998430A (en) 1999-12-07
DE59600683D1 (de) 1998-11-19
ATE172117T1 (de) 1998-10-15
CA2221900C (en) 2007-10-23
JPH10158169A (ja) 1998-06-16
ES2125696T3 (es) 1999-03-01

Similar Documents

Publication Publication Date Title
DK0856312T3 (da) Anvendelse af trospiumchlorid til fremstilling af et lægemiddel til behandling af blæresygdomme
UA41989C2 (uk) Фармацевтична композиція у вигляді гелю для лікування захворювань шкіри та спосіб лікування інфікованої шкіри
SE9404196D0 (sv) New antithrombotic formulation
ATE237330T1 (de) Verabreichung von nikotin im dickdarm zur behandlung von entzündlicher eingeweidenerkrankung
EA200001044A3 (ru) Соединения для лечения женской сексуальной дисфункции
PT1079806E (pt) Preparacoes para a aplicacao de anti-inflamatorios, especialmente, agentes anti-septicos e/ou agentes de promocao da cura de feridas, no tracto respiratorio superior e/ou no ouvido
TR199801180T2 (xx) Aneljestik etkiye sahip yeni bile�ikler.
TNSN94035A1 (fr) Composition veterinaire
HUT76258A (en) Compositions comprising dna damaging agents and p53, and methods for uses thereof
GEP20043269B (en) Purine Derivatives, Method for Their Production and Composition Containing the Same
SE8903914D0 (sv) Oral composition for the treatment of inflammatory bowel diseases
DE69613840D1 (de) Orale dosierungsform und verfahren zur behandlung von schmerzzuständen in dermundhöhle
MXPA02012075A (es) Composicion para mediar el dolor y aparato y metodo para utilizarla.
HUP0202776A2 (hu) (+)-Tramadol, O-demetil-tramadol, (+)-O-demetil-tramadol, O-demetil-N-mono-demetil-tramadol, illetve (+)-O-demetil-N-mono-demetil-tramadol felhasználása vizeletinkontinencia kezelésére alkalmas gyógyszerkészítmény előállítására
AU3324100A (en) Use of pirenoxine for the protection of corneal tissues in photokeratectomy
DE69834724D1 (de) Behandlung von Darm- oder Blasenentzündungen
NO894222L (no) Fremgangsmaater for behandling og profylakse av pneumocytis carinii pneumoni og andre sykdommer og forbindelser og formuleringer for anvendelse i nevnte metoder.
PT941110E (pt) Utilizacao do factor 2 de crescimento dos ceratinocitos
SE9602644D0 (sv) New use
TR199801184T2 (xx) Analjezik tesirli yeni bile�ikler.
DK1251850T3 (da) Anvendelse af et kombinationspræparat i cancerbehandling
HUP9903679A2 (hu) Olanzapin alkalmazása bipoláris zavar kezelésére szolgáló gyógyszerkészítmények előállítására
BR9603454A (pt) Composição e método para tratamento de câncer de próstata
HK1016408A1 (en) Use of a combination of antineoplastons for the manufacture of a medicament for the treatment of neurofibromatosis
PT1140001E (pt) Composicao para tratamento de queimaduras